TITLE

Influence of medications and diagnoses on fall risk in psychiatric inpatients

AUTHOR(S)
Lavsa, Stacey M.; Fabian, Tanya J.; Saul, Melissa I.; Corman, Shelby L.; Coley, Kim C.
PUB. DATE
August 2010
SOURCE
American Journal of Health-System Pharmacy;8/1/2010, Vol. 67 Issue 15, p1274
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose. The influence of medications and diagnoses on fall risk in psychiatric inpatients was evaluated. Methods. In this retrospective case-control study, psychiatric inpatients age 18 years or older with a documented fall that was reported served as study cases. These patients were matched to control patients from the same hospital (1:1) by admission year, sex, and age. Psychiatric diagnoses evaluated included major depressive disorder, schizophrenia or schizoaffective disorder, bipolar disorder, Alzheimer's disease and dementia, anxiety or neurosis, delirium, personality disorder, and obsessivecompulsive disorder. Medications assessed as independent variables were conventional antipsychotics, atypical antipsychotics, selective serotonin-reuptake inhibitors, tricyclic antidepressants, atypical antidepressants, monoamine oxidase inhibitors, lithium, anticonvulsants, benzodiazepines, nonbenzodiazepine sleep aids, Alzheimer's disease medications, antihistamines, antiarrhythmics, antihypertensives, benign prostatic hyperplasia medications, oral hypoglycemic agents, histamine H2-receptor blockers, laxatives and stool softeners, muscle relaxants, nonsteroidal antiinflammatory drugs, opioids, Parkinson's disease medications, and overactive bladder medications. Univariate logistic regression models were developed for each risk factor to determine its impact on fall risk. Results. A total of 774 patient cases were matched with controls. Most falls occurred on the second day of hospitalization. Medications associated with a higher risk of falls were α-blockers, nonbenzodiazepine sleep aids, benzodiazepines, H2-blockers, lithium, antipsychotics, atypical antidepressants, anticonvulsants, and laxatives and stool softeners. Patients with a diagnosis of dementia and Alzheimer's disease also had an increased risk of falling. Conclusion. Alpha-blockers, nonbenzodiazepine sleep aids, benzodiazepines, H2-blockers, lithium, atypical antipsychotics, atypical antidepressants, anticonvulsants and mood stabilizers, conventional antipsychotics, laxatives and stool softeners, and dementia and Alzheimer's disease were significant predictors of inpatient falls in a psychiatric population.
ACCESSION #
52449258

 

Related Articles

  • Psychiatry Revisited. Dean, Charles E. // Minnesota Medicine;Mar2008, Vol. 91 Issue 3, p41 

    The author examines the development in the diagnosis and treatment of psychiatric disorders in Minnesota. It is evident that researchers and medical practitioners have a full understanding on how the brain works as well as the development of antipsychotic agents and antidepressants. However,...

  • Rethink Depression. MAISEL, ERIC // Natural Solutions;Jul/Aug2012, Issue 145, p58 

    The article discusses phenomena of depression and compares it with sign of sadness. It states that the antidepressant chemical which are effective in changing mood may not be an appropriate treatment for depression. It focuses on authentic living where what matters to an individual, his thoughts...

  • Serious mental illness. Shergill, Sukhi; Tracy, Derek // Pulse;5/25/2011, Vol. 71 Issue 19, p21 

    The article offers information on the management and treatment of patients suffering from serious mental illness including schizophrenia, bipolar affective disorder, and schizoaffective disorders. It details the prevalence, symptoms, and treatment of mental disorders as well as the monitoring of...

  • Revisión de la historia del trastorno esquizoafectivo y su relación con los rasgos de personalidad. Borrero, Álvaro Arenas; Prada, Adriana Rogelis // Universitas Médica;abr-jun2006, Vol. 47 Issue 2, p147 

    We present a literary revision of the history of schizoaffective disorder and his place in the modern diagnosis classification system. We address the importance of personality traits in the diagnosis and management of schizoaffective disorder, we review also the importance of the study of...

  • Tests, testing, and tested - we need to critically evaluate the meaning of tests in psychiatry. Berger, Douglas M. // Indian Journal of Psychiatry;Apr-Jun2013, Vol. 55 Issue 2, p200 

    This article describes clinical pitfalls in our concepts of what it means for an illness, diagnosis, or evaluation and treatment methods to say that they have been "tested". This articles begins with the problems encountered in newborn testing for Krabbe Disease of the nervous system in New York...

  • Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Iran, Pierre V.; Tollefson, Gary D.; Sanger, Todd M.; Yili Lu; Berg, Paul H.; Beasley Jr., Charles M. // British Journal of Psychiatry;Jan99, Vol. 174, p15 

    Background The effectiveness of antipsychotic monotherapy in schIzoaffective disorder is limited, and further constrained by safety concerns. Aims We aimed to compare the efficacy, tolerability and safety profile of the new pharmaceutical, olanzapine, with haloperidol. Method Data were assessed...

  • Psychological Medicine. Gilbert, John C. // British Medical Journal;4/10/1976, Vol. 1 Issue 6014, p882 

    Focuses on the drugs used in treating psychological disorders. Discovery of the potent antipsychotic agent, haloperidol; Powerful tranquilizing effect of reserpine; Effectiveness of tricyclic antidepressants in treating depressive illness.

  • Will the new antipsychotics improve the treatment of schizophrenia? Hale, Tony // BMJ: British Medical Journal (International Edition);9/25/93, Vol. 307 Issue 6907, p749 

    Focuses on the impact of non-compliance with neuroleptic treatment to the success of treatment for mental illness. Emphasis in minimization of extrapyramidal side effects; Improvement of compliance through creative approaches; Role of drug related depression and psychological factors on compliance.

  • Brain circuitry model will transform mental health research. White, Caroline // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/10/2011, Vol. 343 Issue 7822, p500 

    The article reports on the revelation of the U.S. National Institute of Mental Health regarding the transformation mental health services to better provide diagnosis and treatment of such disease, as well as improve the lack of major progress in the field.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics